Cerevel Therapeutics Holdings, Inc. - COM (CERE)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
152 M
Holdings value Q1 2024
$6.42 B
Value change Q1 2024
-$58.9 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
195
Number of buys Q1 2024
118
Number of sells Q1 2024
-75
Average buys Q1 2024 %
+0.005%
Average sells Q1 2024 %
-0.003%
CUSIP
15678U128
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 152 M $6.42 B -$58.9 M $42.27 195
2023 Q4 153 M $6.47 B +$610 M $42.40 193
2023 Q3 140 M $3.06 B +$4.64 M $21.83 122
2023 Q2 138 M $4.39 B +$95.8 M $31.79 124
2023 Q1 135 M $3.3 B +$30.8 M $24.39 119
2022 Q4 134 M $4.23 B +$34.5 M $31.54 127
2022 Q3 132 M $3.73 B +$181 M $28.26 110
2022 Q2 124 M $3.28 B +$48.5 M $26.44 105
2022 Q1 122 M $4.27 B +$122 M $35.01 101
2021 Q4 119 M $3.84 B -$14.5 M $32.42 101
2021 Q3 119 M $3.51 B +$480 M $29.50 91
2021 Q2 103 M $2.65 B +$114 M $25.62 82
2021 Q1 99.9 M $1.37 B +$37.4 M $13.73 60
2020 Q4 94.3 M $1.56 B +$1.53 B $16.58 53